Quotient Ltd (NASDAQ:QTNT) Director Prondzynski Heino Von bought 12,000 shares of the business’s stock in a transaction on Wednesday, February 21st. The stock was acquired at an average cost of $4.28 per share, for a total transaction of $51,360.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.
Quotient Ltd (NASDAQ QTNT) traded up $0.01 on Friday, hitting $4.47. The stock had a trading volume of 215,800 shares, compared to its average volume of 550,659. The company has a current ratio of 2.34, a quick ratio of 1.65 and a debt-to-equity ratio of 22.54. Quotient Ltd has a 52 week low of $2.78 and a 52 week high of $7.74.
Quotient (NASDAQ:QTNT) last released its quarterly earnings results on Monday, February 5th. The company reported ($0.47) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.55) by $0.08. The company had revenue of $5.86 million for the quarter, compared to analysts’ expectations of $5.20 million. Quotient had a negative return on equity of 13,050.41% and a negative net margin of 342.23%. analysts anticipate that Quotient Ltd will post -2.07 earnings per share for the current year.
QTNT has been the topic of a number of recent research reports. Jefferies Group cut their target price on shares of Quotient from $15.00 to $13.00 and set a “buy” rating on the stock in a report on Wednesday, November 1st. BTIG Research reissued a “buy” rating and issued a $12.00 target price on shares of Quotient in a report on Wednesday, November 1st. Finally, Zacks Investment Research cut shares of Quotient from a “hold” rating to a “sell” rating in a report on Thursday, November 2nd.
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Perceptive Advisors LLC raised its holdings in shares of Quotient by 61.9% during the fourth quarter. Perceptive Advisors LLC now owns 6,033,020 shares of the company’s stock valued at $29,683,000 after buying an additional 2,306,034 shares during the last quarter. Clearbridge LLC raised its holdings in shares of Quotient by 53.2% during the fourth quarter. Clearbridge LLC now owns 2,562,084 shares of the company’s stock valued at $12,682,000 after buying an additional 890,050 shares during the last quarter. Ameriprise Financial Inc. raised its holdings in shares of Quotient by 5.0% during the third quarter. Ameriprise Financial Inc. now owns 1,921,259 shares of the company’s stock valued at $9,472,000 after buying an additional 91,364 shares during the last quarter. Prosight Management LP bought a new stake in shares of Quotient during the fourth quarter valued at approximately $4,616,000. Finally, Millennium Management LLC raised its holdings in shares of Quotient by 106.4% during the fourth quarter. Millennium Management LLC now owns 503,735 shares of the company’s stock valued at $2,493,000 after buying an additional 259,715 shares during the last quarter. 50.43% of the stock is currently owned by institutional investors.
WARNING: This piece of content was originally reported by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright legislation. The correct version of this piece of content can be read at https://www.thelincolnianonline.com/2018/02/23/quotient-ltd-qtnt-director-prondzynski-heino-von-purchases-12000-shares-of-stock.html.
Quotient Limited is a diagnostics company. The Company focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market.
Receive News & Ratings for Quotient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quotient and related companies with MarketBeat.com's FREE daily email newsletter.